Abstract |
The tyrosine kinase receptor EphB4 is frequently overexpressed in ovarian and other solid tumors and is involved in interactions between tumor cells and the tumor microenvironment, contributing to metastasis. Trans-interaction between EphB4 and its membrane-bound ligand ephrin B2 (EFNB2) mediates bi-directional signaling: forward EFNB2-to-EphB4 signaling suppresses tumor cell proliferation, while reverse EphB4-to-EFNB2 signaling stimulates the invasive and angiogenic properties of endothelial cells. Currently, no small molecule-based, dual-function, EphB4-binding peptides are available. Here, we report our discovery of a bi-directional ephrin agonist peptide, BIDEN-AP which, when selectively internalized via receptor-mediated endocytosis, suppressed invasion and epithelial-mesenchymal transition of ovarian cancer cells. BIDEN-AP also inhibited endothelial migration and tube formation. In vivo, BIDEN-AP and its nanoconjugate CCPM-BIDEN-AP significantly reduced growth of orthotopic ovarian tumors, with CCPM-BIDEN-AP displaying greater antitumor potency than BIDEN-AP. Both BIDEN-AP and CCPM-BIDEN-AP compromised angiogenesis by downregulating epithelial-mesenchymal transition and angiogenic pathways. Thus, we report a novel EphB4-based therapeutic approach against ovarian cancer.
|
Authors | Chiyi Xiong, Yunfei Wen, Jun Zhao, Dengke Yin, Lingyun Xu, Anca Chelariu-Raicu, Cody Yao, Xiaohong Leng, Jinsong Liu, Rajan R Chaudhari, Shuxing Zhang, Anil K Sood, Chun Li |
Journal | Scientific reports
(Sci Rep)
Vol. 10
Issue 1
Pg. 520
(01 16 2020)
ISSN: 2045-2322 [Electronic] England |
PMID | 31949258
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- EFNB2 protein, human
- EPHB4 protein, human
- Ephrin-B2
- Ephrins
- Micelles
- Peptides
- Receptor, EphB4
|
Topics |
- Animals
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Ephrin-B2
(metabolism)
- Ephrins
(agonists)
- Epithelial-Mesenchymal Transition
(drug effects)
- Female
- Humans
- Mice
- Micelles
- Ovarian Neoplasms
(drug therapy, metabolism)
- Peptides
(administration & dosage, genetics, pharmacology)
- Phosphorylation
- Protein Binding
(drug effects)
- Receptor, EphB4
(metabolism)
- Signal Transduction
(drug effects)
- Tumor Microenvironment
(drug effects)
- Xenograft Model Antitumor Assays
|